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This review describes the interactions between the pedunculopontine nucleus (PPN), the
ventral tegmental area (VTA), and the thalamocortical system. Experiments using mod-
ulators of cholinergic receptors in the PPN clariﬁed its role on psychostimulant-induced
locomotion. PPN activation was found to be involved in the animal’s voluntary search for
psychostimulants. Every PPN neuron is known to generate gamma band oscillations.
Voltage-gated calcium channels are key elements in the generation and maintenance of
gamma band activity of PPN neurons. Calcium channels are also key elements mediating
psychostimulant-induced alterations in the thalamic targets of PPN output. Thus, the PPN
is a key substrate for maintaining arousal and REM sleep, but also in modulating
psychostimulant self-administration.
& 2015 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Wake–sleep control by the Reticular
Activating System and its inﬂuence on substance
abuse
Substance abuse and the perception of withdrawal/relapse are
mediated by neurobiological processes that occur when we are
awake, but not when we are asleep. Furthermore, sleep dis-
turbances (i.e., sleep deprivation) have been considered a risk forep. Production and Hosti
licenses/by-nc-nd/4.0/).
nal Neuroscience, Depart
1 West Markham St., Litt
u (E. Garcia-Rill).
an Association of Sleep.psychotimulant abuse. The Reticular Activating System (RAS)
plays a central role controlling sleep homeostasis, modulating
oscillatory rhythms between the thalamus and cortex that are
distinguishable in the EEG during wake–sleep states [1]. The
interactions between the pedunculopontine nucleus (PPN) and
the thalamus are critical to its function of wake–sleep control,
exerting a push–pull effect on two centers. That is, the PPN
inhibits the reticular thalamic nucleus (RTN) (which decreases
slow waves during sleep), and excites speciﬁc thalamic relayng by Elsevier B.V. This is an open access article under the CC BY-
ment of Neurobiology and Developmental Sciences, University of
le Rock, AR 72205, USA. Tel.: þ1 501 686 5167; fax: þ1 501 526 7928.
Fig. 1 – Schematic diagram showing psychostimulants/
neuromodulators of PPN and thalamocortical circuits.
Projections from PPN to key dopaminergic nuclei underlying
psychostimulant effects. The PPN projects to the ventral
tegmental area (VTA) and substantia nigra (SN).
Dopaminergic VTA neurons in turn project to the medial
prefrontal cortex (mPFC) and nucleus accumbens (NAcc).
Amphetamines/cocaine (two stimulants that exert their
effects by drastically increasing extracellular DA
concentration) self-administration can be modulated by PPN
efferents to VTA and SN. Cholinergic modulation by the PPN
can modulate VTA and thalamic nuclei, exciting
glutamatergic relay neurons while inhibiting GABAergic
reticular thalamic neurons. Upper left box: (þ) represents
excitatory, glutamatergic or cholinergic synapses, and ( )
GABAergic, or cholinergic inhibitory synapses.
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(Fig. 1) [2,3]. Thalamic relay neurons (which by deﬁnition send
glutamatergic projections to the cortex) also receive RTN
(GABAergic) afferents whose axons remain within the bound-
aries of the dorsal thalamic nucleus where the somata are
located [4]. Thalamic relay neurons are bushy and, depending
on the size of the soma, project to different layers of the cortex
[5,6]. RTN neurons, on the other hand, have axons that collater-
alize within the nucleus and also project to dorsal thalamic
nuclei, but not to the cortex; they have long dendrites, whose
secondary and tertiary branches possess vesicle-containing
appendages that form synapses on the dendrites of other
reticular neurons [7]. The cells of the RTN are electrically coupled
via gap junctions, providing a coherent recurrent inhibitory
signal to thalamic relay cells, causing activation of T-type
calcium channels responsible for slow waves during sleep [8].
Therefore, cholinergic afferents from the PPN to the RTN are
inhibitory (pull away from slow wave sleep) [9], but excitatory to
thalamic relay neurons (push towards waking). This prevents the
bursting mediated by the activation of T-type calcium channels
by RTN inhibition [10], and tonically depolarizes thalamic relay
neurons, thus inducing a global disinhibition of thalamocortical
activity. That is, when the PPN is activated, slow wave sleep is
reduced and arousal is increased.
Altered thalamocortical dynamics are the basis for several
types of neurological and neuropsychiatric conditions named
thalamocortical dysrhythmia syndrome [11,12]. Abnormal activity of
relay neurons has been related to an increase of low frequencyoscillatory activity due to protracted activation of the low thresh-
old voltage-activated (LVA) T-type calcium currents (CaV3
mediated), and in turn relayed to the cortical mantle resulting
in a mistiming between sensory and arousal inputs. In summary,
an enhancement of low frequency thalamocortical activity during
awake states would underlie aberrant sensory processing [13].
The ventral tegmental area (VTA) is a key neural substrate
involved in the modulation of psychostimulant abuse, and its
output is essential for the rewarding effects of addictive drugs
[14]. The VTA receives cholinergic RAS input from the PPN,
which modulates the high frequency states of waking and rapid
eye movement (REM) sleep (Fig. 1) [1]. Cholinergic efferents from
the PPN to the VTA are part of a loop that includes the medial
prefrontal cortex (mPFC) [15]. This loop is composed of mPFC
glutamatergic efferents to dopaminergic and GABAergic neurons
in the VTA and to the nucleus accumbens (NAcc) through a
polysynaptic circuit that includes the PPN. In addition, the VTA
sends dopaminergic and GABAergic efferents to the NAcc.
Activation of the PPN thus increases VTA dopaminergic output,
and increases extracellular dopamine (DA) levels in the NAcc
and mPFC [16], which suggests that the PPN in part regulates the
reward and motivational functions of the VTA [17].
Higher glutamatergic efferent activation from the mPFC
would in turn reduce VTA dopaminergic output through its
direct activation of local GABAergic interneurons within the
VTA. Recent optogenetic experiments conﬁrmed that PPN-
VTA pathway stimulation can elicit psychostimulant-like
behavior in the absence of any drug administration [18].
Since midbrain dopaminergic neurons originating in the
VTA and substantia nigra pars compacta (SNc) have been
previously described as the neural substrates underlying
individual vulnerability to psychostimulant addiction [19–
21], elucidating the functional modulation of the VTA and
SNc by the PPN is a key to understanding how drug reinfor-
cing, craving, and psychomotor-stimulant effects are modu-
lated by a wake-promoting nuclei such as the PPN.2. Drugs of abuse as modulators of calcium
channels in the PPN and its targets
Psychostimulants—like thalamic relay neurons, about 40% of
PPN cells have T-type calcium channels that mediate low
threshold spikes (LTS) [1]. However, the most common calcium
channels in the PPN are high threshold voltage-dependent
calcium channels. Our group found that every PPN neuron has
N- and/or P/Q-type calcium channels [22], which mediate beta/
gamma band intrinsic membrane oscillations [23]. PPN cal-
cium channels, in particular the P/Q-type, are modulated by
muscarinic M2 receptors, providing a physiologically relevant
ﬁne-tuning of beta/gamma band oscillations in this nucleus
[23]. P/Q-type (Cav2.1) calcium channels are widely distributed
in the CNS [24,25], and play a central role in the physiology of
PPN [26–28], as well as its thalamocortical targets [13,29]. High
threshold voltage-dependent calcium channels, and P/Q-type
channels in particular, have been described in presynaptic
terminals mediating synaptic transmission in both glutama-
tergic pyramidal and inhibitory interneurons [24,25]. Using
two-photon imaging, P/Q-type channels have been located in
the dendritic compartments of thalamocortical neurons [29].
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associated with distal dendritic compartments [27,28]. These
calcium channels are critical to the induction and mainte-
nance of high frequency oscillation states like waking and REM
sleep [22,23,27,28]. The study of the effects of psychostimu-
lants on these channels is critical to determining the role of
the PPN in psychostimulant abuse.Fig. 2 – Illustration of psychostimulant/neuromodulator
dependent turnover of calcium and cationic
hyperpolarization-activated IH currents on PPN and
thalamocortical neurons. Systemic administration of
cocaine is known to up-regulate membrane expression of
T-type calcium and IH cationic currents [49–51]. Systemic
administration of METH reduced P/Q type calcium channel
currents in medial prefrontal cortex (mPFC) [36]. In addition,
nicotine upregulated IH cationic current density in PPN
neurons (Garcia-Rill et al. [80]).2.1. Amphetamines
Amphetamine and methamphetamine induce increases in
extracellular DA by acting in the terminals and cell bodies of
midbrain DA neurons, where they induce the reverse transport
of DA and prevent its uptake [30,31]. Amphetamine is known to
enhance cyclin-dependent kinase 5 (cdk5) activity [32], contri-
buting to neuroadaptations underlying locomotor sensitization
[33]. Cdk5-mediated intracellular pathways are known to down-
regulate P/Q-type calcium channels [34,35], which would med-
iate thalamocortical dysrhythmic interactions by unbalancing the
normal P/Q-type vs T-type channels activation ratio [13].
Lowered PPN gamma band output is also to be expected after
cdk5 activation, which would alter normal wake/REM sleep
transitions [1]. Moreover, the effects of methamphetamine on
the mPFC network has been recently found to alter calcium
dynamics (by reducing calcium current density) in pyramidal
neurons, while enhancing cationic hyperpolarization-activated
IH current density (Fig. 2) (that could also increase low-
frequency ﬁring) [36]. Additionally, methamphetamine induced
lower levels of glutamatergic synaptic transmission in the
mPFC, which has been suggested to underline the mPFC
hypofunctionality described in human addicts [36].
The basic behavioral effect of amphetamines is to induce
hyperlocomotion, which can be used as a predictor of future
propensity to amphetamine self-administration [37]. Acute
total sleep deprivation has been described to potentiate
amphetamine-induced locomotion [38]. Direct interactions
between the PPN and VTA were demonstrated using excito-
toxic lesions of the PPN [39]. GABAergic neuronal ﬁring rates
decrease during slow wave sleep and increase during REM
sleep [40], suggesting a novel PPN control over VTA. More
experiments are needed to further clarify this possibility as
well as its possible modulation by psychostimulants.
PPN-lesioned animals showed a clear reduction in the
response to a progressive ratio self-administration schedule of
amphetamine [39]. Lesions of the PPN blocked the motivational
(measured using a conditioned place preference paradigm) effects
of amphetamine [41]. Muscarinic agonists have been shown to
reduce amphetamine-induced hyperlocomotion [42], while mus-
carinic antagonistsmediated facilitation of amphetamine-induced
rotation through M2 receptors [43]. Unfortunately, all of these
experiments were performed using systemic administration of
muscarinic receptor modulators, making it difﬁcult to determine
the exact neural substrate of these actions in the brain (i.e., it is
possible that muscarinic receptor modulation might affect the
activity of other cholinergic nuclei such as the nucleus basalis that
projects to cortex and to the RTN) [44].2.2. Cocaine
The rewarding properties and abuse potential of cocaine is
derived in part from elevated levels of DA neurotransmission in
limbic circuits [45,46]. Cocaine can also increase serotonin
(5-HT) neurotransmission via inhibition of its re-uptake [47].
Individual vulnerability to cocaine self-administration has been
associated with changes in neuronal intrinsic properties, in
particular, with higher action potential frequency and bursting
of VTA neurons, and to a lesser extent SNc neurons. In addition,
animals that manifested higher self-administration rates also
exhibited higher locomotor responses to a novel environment
prior to psychostimulant-administration [48], strongly suggest-
ing that the basal modulation of VTA neurons by the PPN can
be considered critical to psychostimulant abuse liability.
While Schmidt et al. [49] showed that enhanced glutama-
tergic transmission in the PPN promoted cocaine priming-
induced reinstatement of cocaine seeking, others [50] used
the infusion of a diphtheria toxin conjugated to urotensin-II
into the PPN (which resulted in the loss of 495% of PPN
cholinergic neurons) to describe no signiﬁcant alterations in
cocaine self-administration. A possible explanation for the
discrepancies described in recent years may be related to the
strong serotonergic effects of cocaine [47]. Indeed, cocaine-
mediated blocking effects of both DA and serotonin reuptake
could alter the activity of PPN efferents to VTA, as well as the
degree of activation of serotonergic afferents from the raphe
nuclei to the PPN. Such a possibility has been recently
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methylphenidate on GABAergic transmission in mouse ven-
trobasal thalamic nucleus [51]. A cocaine-mediated enhance-
ment in GABA release has been described to induce
thalamocortical dysrhythmic interactions in mice due to the
over activation of T-type calcium channels expressed in
thalamocortical neurons (Fig. 2) [52]. Indeed, pre-treatment
with T-type channel blockers was shown to prevent the
effects of cocaine on the thalamocortical system, suggesting
a new role mediating GABA release of the T-type channels
located in the presynaptic terminals of parvalbumin-rich
reticular thalamic neurons [53]. After three-day systemic
treatment with cocaine, both T-type and P/Q-type calcium
channels were over expressed [51], suggesting a compensa-
tory mechanism by which thalamocortical neurons attempt
to cope with the deleterious effects of cocaine.
Acute total sleep deprivation potentiated cocaine-induced
hyperlocomotion in mice [54]. Therefore, PPN activation is
important in the modulation of cocaine self-administration,
although the mechanisms underlying such an effect need
further characterization.
2.3. Modaﬁnil, a non-addictive psychostimulant, deserves
separate discussion
We found that the prescription drugmodaﬁnil, which is used for
the treatment of narcolepsy and daytime sleepiness, prevented
the neurotoxic effects of methamphetamine on striatal circuits
[55,56]. Modaﬁnil acts by increasing electrical coupling especially
in GABAergic neurons [58,59], which decreases input resistance
in GABAergic cells throughout the brain, but particularly in the
PPN. Such an effect would disinhibit glutamatergic and dopa-
minergic interactions between PPN and VTA nuclei. In addition,
modaﬁnil can counteract methamphetamine-mediated impair-
ments in mPFC function [57,60], which is a key area regulating
cognition and normal sleep physiology [58,61]. More studies are
still needed in order to address the possible role of calcium
channels in the apparent cognitive-enhancing proﬁle of mod-
aﬁnil for the treatment of deﬁcits mediated by metham-
phetamine.
Modaﬁnil is known to mediate its effect on thalamocor-
tical neurons through a CaMKII-dependent intracellular path-
way [59] that has been described to enhance P/Q-type
channel function [62]. These mechanisms might explain
why modaﬁnil-mediated over activation of the CaMKII intra-
cellular pathways can lead to enhance walking time.
2.4. Nicotine
Nicotinic receptor agonists induced a depolarization early in
development (day 12) that switched across days 15–17 until
they elicited hyperpolarization by day 21 in the rat PPN [63].
Nicotine has also been found to have an inhibitory effect on
the PPN, initially reducing arousal. This may explain the initial
anxiolytic effects of cigarette smoke [64,65]. Nicotine in the
fetus may have long-term consequences on RAS activity.
Nicotine from cigarette smoke can cross the placenta, expos-
ing the fetuses from smoking mothers to higher nicotine
concentrations in both amniotic ﬂuid and umbilical vein than
the ones in maternal vein serum [66]. Toxicological effects ofperinatal cigarette smoke exposure include lower birth weight
[67], higher rate of spontaneous abortion [68], and increased
incidence of sudden infant death syndrome [69]. Maternal
smoking during pregnancy can lead to increased aggression
[70], and problems with sustained attention and impulsivity in
adolescent offspring [71]. Children of smoking mothers are at
increased risk behavior problems [72,73], behavioral disorders
[74,75], drug abuse [70], and for high rates of violent and
persistent criminal offenses [70,76].
Behavioral deﬁcits related to arousal and attentional pro-
blems in humans have been identiﬁed in rats exposed to
nicotine prenatally. These animal models show deﬁcits in
attention and memory in maze performance [77,78], learning
[77], and operant behaviors [79]. We studied the effects of
prenatal exposure to cigarette smoke on the physiology of PPN
cells postnatally [80]. We found that PPN neurons exhibited
lower resting membrane potential and lower action potential
threshold (tending to increase PPN ﬁring), both of which could be
related to an increase in hyperpolarization-activated IH current
(that could also increase low-frequency ﬁring). IH current
enhancement has been also described for cocaine-mediated
effects on thalamocortical neurons (Fig. 2) [52]. IH and T-type
currents have been described to mediate low frequency oscilla-
tory activity in the thalamaocortical system [52]. We speculate
that hyperpolarization-activated cyclic nucleotide-gated proteins
may be over activated by prenatal cigarette smoke exposure, and
that a possible down regulation of IH proteinsmay be responsible
for the enhancement in arousal as well as for the attentional
deﬁcits [72], as well as impulse control problems (exaggerated
ﬁght-or-ﬂight responses) reported in the children of mothers
who smoked during pregnancy [71,73].3. Conclusion
Drug abuse is a major global health problem. Although some
people that have suffered from psychostimulant abuse are
able to recover, relapse occur in almost half of the cases. Also,
addicts to drugs of abuse have shown persistent neuropatho-
logical changes that may be related to the profound dysfunc-
tion present in addict populations [81]. Thus, psychostimulant
addiction is treated like a chronic illness, requiring repeated
episodes of therapy. The symptoms of relapse are similar to
those in depression and anxiety, which may require pharma-
cological therapy in addition to cognitive therapy and support
groups. These functions all involve arousal and, therefore, the
RAS. For example, impaired sleep is present during with-
drawal, and insomnia-like symptoms are present in heroin,
cocaine, methamphetamine, and addicted users of other drugs
[82]. Basically, disturbed sleep predicts relapse to alcohol and
psychoactive drug abuse [83]. Just as with psychiatric and
neurological disorders, rebalancing the wake–sleep homeo-
static system is key to treatment response and, in fact, signals
successful alleviation of symptoms. In addition, future work
characterizing the role of psychostimulants on voltage-gated
calcium channels in the RAS and target areas may shed some
light on their mechanisms and their possible treatment.
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